Yoga for reducing cardiovascular risk in obesity and overweight.
- Conditions
- Health Condition 1: E663- Overweight
- Registration Number
- CTRI/2022/10/046169
- Lead Sponsor
- S-VYASA Deemed to be University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
•Age 18 years to 40 years (Both genders)
•BMI = 23 kg/m2 to = 30kg/m2
•Diagnosis of or receiving treatment for at least one month of the following medical conditions associated with increased CVD risk within the past 12 months: hyperlipidemia or dyslipidemia (documented diagnosis, low-density lipoprotein =160 mg/dL, or receiving statin or other treatment), hypertension (documented diagnosis or blood pressure of =140/90 mmHg on 2 occasions)
•Smokers/ individuals with history of tobacco consumption will be included in the study
•Willing to participate in the study and accept randomization.
•Cardiovascular event (unstable angina, myocardial infarction) within the past 6 months.
•Surgeries in the past 6 months.
•Participants with known/self-report of chronic kidney disease, Atrial Fibrillation, Sepsis, Liver cirrhosis and depression.
•Current diagnosis of arteriosclerotic cardiovascular disease.
•Acute viral/pathogen mediated infections in past 3 months
•Condition which interferes with outcome measurement.
•Pregnant or planning a pregnancy during study period. Nursing mothers would need approval from physician.
•Medically restricted from physical activity.
•Known medical history of inflammatory and autoimmune diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Soluble urokinase plasminogen activator receptor (suPAR) <br/ ><br>2. High-Sensitivity C-reactive protein (hsCRP) <br/ ><br>3. Framingham Risk ScoreTimepoint: baseline and post intervention
- Secondary Outcome Measures
Name Time Method Anthropometric Measurement <br/ ><br> <br/ ><br>International Physical Activity Questionnaire (IPAQ) <br/ ><br> <br/ ><br> <br/ ><br>Body Shape Questionnaire (BSQ) <br/ ><br> <br/ ><br>Obesity Related Well-Being (ORWELL-97) <br/ ><br> <br/ ><br>Rosenberg Self-Esteem Scale (RSE) <br/ ><br> <br/ ><br>Weight Related Symptom Measure (WRSM) and Obesity and Weight <br/ ><br>Loss Quality of Life (OWLQOL) <br/ ><br>Timepoint: baseline and post intervention